HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vector transmission of leishmania abrogates vaccine-induced protective immunity.

Abstract
Numerous experimental vaccines have been developed to protect against the cutaneous and visceral forms of leishmaniasis caused by infection with the obligate intracellular protozoan Leishmania, but a human vaccine still does not exist. Remarkably, the efficacy of anti-Leishmania vaccines has never been fully evaluated under experimental conditions following natural vector transmission by infected sand fly bite. The only immunization strategy known to protect humans against natural exposure is "leishmanization," in which viable L. major parasites are intentionally inoculated into a selected site in the skin. We employed mice with healed L. major infections to mimic leishmanization, and found tissue-seeking, cytokine-producing CD4+ T cells specific for Leishmania at the site of challenge by infected sand fly bite within 24 hours, and these mice were highly resistant to sand fly transmitted infection. In contrast, mice vaccinated with a killed vaccine comprised of autoclaved L. major antigen (ALM)+CpG oligodeoxynucleotides that protected against needle inoculation of parasites, showed delayed expression of protective immunity and failed to protect against infected sand fly challenge. Two-photon intra-vital microscopy and flow cytometric analysis revealed that sand fly, but not needle challenge, resulted in the maintenance of a localized neutrophilic response at the inoculation site, and removal of neutrophils following vector transmission led to increased parasite-specific immune responses and promoted the efficacy of the killed vaccine. These observations identify the critical immunological factors influencing vaccine efficacy following natural transmission of Leishmania.
AuthorsNathan C Peters, Nicola Kimblin, Nagila Secundino, Shaden Kamhawi, Phillip Lawyer, David L Sacks
JournalPLoS pathogens (PLoS Pathog) Vol. 5 Issue 6 Pg. e1000484 (Jun 2009) ISSN: 1553-7374 [Electronic] United States
PMID19543375 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • Leishmaniasis Vaccines
  • Vaccines, Attenuated
Topics
  • Animals
  • CD4 Lymphocyte Count
  • CD4-Positive T-Lymphocytes (immunology)
  • Cells, Cultured
  • CpG Islands (immunology)
  • Disease Models, Animal
  • Epidermis (immunology)
  • Female
  • Flow Cytometry
  • Inflammation (immunology)
  • Insect Vectors (parasitology)
  • Leishmania major (immunology)
  • Leishmaniasis (immunology, prevention & control, transmission)
  • Leishmaniasis Vaccines (administration & dosage, immunology)
  • Mice
  • Mice, Inbred C57BL
  • Neutrophils (immunology)
  • Psychodidae (parasitology)
  • Statistics, Nonparametric
  • Vaccines, Attenuated (administration & dosage, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: